The withdrawal of market approval, which was decided in March, came into force on Tuesday, according to a document from the EU Commission. Astrazeneca had requested this step itself “for commercial reasons”, the company confirmed in response to a request from the German Press Agency on Tuesday. The background is a lack of demand.
Since the end of the pandemic, several variants of Covid-19 vaccines have been developed, which is why there is now a surplus of updated preparations available. “This has led to a decrease in demand for Vaxzevria, which is no longer manufactured or supplied,” Astrazeneca said in a statement. But they are “incredibly proud of the role Vaxzevria played in ending the global pandemic.”
The EU Commission said in a statement that it was not unusual for companies to request the withdrawal of marketing authorization for medicines or vaccines for commercial reasons. It can be confirmed “that the decision is not based on doubts about the safety or effectiveness of the vaccine,” the statement continued.
My themes
For your saved topics were
new articles found.
info By clicking on the icon you can add the keyword to your topics.
info
By clicking on the icon you open your “my topics” page. They have of 15 keywords saved and would have to remove keywords.
info By clicking on the icon you can remove the keyword from your topics.
Add the topic to your topics.
Source: Nachrichten
